An obstetrician-gynecologist takes a medical director role at a regional health plan. The work suits her. She reviews thousands of charts a year, writes coverage policy, sits on a quality committee, and keeps her license, her board certification, and her continuing education current the entire time.

Four years in, she wants back in the operating room.

The hospital asks for recent case volume. She has none. The liability carrier declines to write a policy for a surgeon who has not operated in four years. The state board treats her as clinically inactive and wants an approved re-entry plan first, and the plan requires supervised cases she has no privileges to perform. Every answer waits on one of the others.

Versions of this arrive at specialty societies every week. The physicians involved left in good standing. They stepped away for illness, caregiving, military service, administrative work, or a stretch of teaching. Their competence is not in question, and their motivation is obvious. What stops them is a system with no front door.

Vocabulary decides which track you land on, so start there. The Federation of State Medical Boards (FSMB) draws hard lines between three terms physicians use interchangeably.

An obstetrician-gynecologist who wants to practice family medicine needs retraining. An obstetrician-gynecologist narrowing scope to gynecology alone stays on the re-entry track and skips retraining entirely. Land in the wrong category and you spend months on the wrong pathway. Physicians who describe themselves as needing retraining often need re-entry, which costs less and moves faster.

The FSMB House of Delegates adopted a new re-entry policy in April 2025, combining two earlier reports and updating guidance for state boards. It names two years away from practice as the commonly accepted threshold for requiring a re-entry process, based on board experience and expert judgment rather than a controlled study.

The report also asks boards to treat the threshold as a starting point, not a switch. Decisions belong on a case-by-case basis, weighing:

Read that list as a scoring rubric. A physician who kept certification current, logged CME, taught in the specialty, and plans a narrower scope walks in with a strong file. One who let everything lapse walks in with a weak one. The difference shows up in the length and cost of the plan a board approves.

Physicians conflate these constantly, and the confusion wastes months.

Then there is the sequence problem. In most jurisdictions a physician cannot obtain liability insurance without a license. Hospitals will not grant privileges without a license and insurance. A physician whose re-entry plan requires direct patient care needs a license to do the very training the license depends on.

Some states solve this with a training, limited, temporary, or resident license. Others have no such category, and the FSMB report asks boards to check whether their license types close this loop. Ask your board directly which license permits supervised patient care during a re-entry program. The answer shapes everything downstream.

The 2025 policy separates the two roles with precision, and the distinction affects cost, availability, and paperwork. A supervisor operates under a board mandate and reports to the board on your competence. The FSMB describes the ideal supervisor as someone in active practice for five consecutive years, certified by the American Board of Medical Specialties (ABMS) or the American Osteopathic Association Bureau of Osteopathic Specialists (AOA BOS), free of discipline over the prior five years, and practicing in your clinical area. A mentor is a peer, with no board approval and no reporting duty beyond what any clinician carries.

Finding either one is the hardest logistical step in re-entry. Boards struggle to identify them. Physicians cold-call for them. The FSMB recommends boards build rosters of willing supervisors and mentors, recruit through renewal applications, and consider naming supervisors agents of the board to shield them from liability. Where boards accept a mentor instead of a supervisor, the barrier drops sharply.

Re-entry programs split into two types. Assessment programs dominate the market. They run two days or so and examine the cognitive side of practice through standardized patient encounters, chart review, multiple-choice testing, cognitive screening, and structured interviews. They produce a written report and an individualized education plan. Several run the assessment remotely and place the clinical phase with a preceptor in your own community.

Retraining programs run weeks to months. They cover knowledge and clinical reasoning well. They cover manual surgical skills unevenly.

Both types share a structural weakness worth stating plainly. No accrediting body reviews the content of re-entry programs. The American College of Obstetricians and Gynecologists (ACOG) made this point in Committee Opinion 523 and has not endorsed any program. Neither has any other specialty society adopted standards for re-entry programs or for how hospitals should credential a re-entering physician. Simulation and procedural certification remain individualized.

Costs reflect the labor involved. Published figures run from roughly $6,750 to more than $20,000 for the program alone, before travel, living expenses, and lost income. The FSMB concedes the expense and calls it necessary for patient safety.

Procedural specialties carry the heaviest re-entry burden, and the published evidence in obstetrics and gynecology is thin enough to be worth reading in full.

Certification adds another layer. The American Board of Obstetrics and Gynecology allows a diplomate to carry a "not currently in practice" designation, with a reduced set of continuing certification requirements and a simple notification to lift it on return. A diplomate who let continuing certification lapse faces a re-entry examination instead. Osteopathic physicians run the same question through the American Osteopathic Board of Obstetrics and Gynecology. Both boards have revised their programs recently, so confirm current terms directly rather than relying on a summary.

Then the proctor problem arrives. ACOG's committee opinion states it bluntly: even when a hospital accepts the application, finding a staff physician willing to proctor through the provisional period is difficult. Proctoring takes time, carries risk, and pays nothing in most arrangements. A re-entering surgeon competes with residents for the same cases.

Three stages, each with its own tasks.

The FSMB survey behind the 2025 report contains a quiet indictment.

The profession does not know the size of this population. It has no standards for the programs serving them, no accreditation for those programs, no specialty-society benchmarks for credentialing a returning physician, and a supervisor pool assembled by cold call.

Meanwhile the case for fixing it strengthens every year. These physicians are trained, licensed, motivated, and already in the country. In obstetrics and gynecology, where access to care keeps contracting, turning away a competent returning physician over a paperwork loop is a workforce decision as much as a regulatory one.

The FSMB names the parties who should build the fix: academic medical centers, community hospital training centers, certifying boards, state medical societies, physician health programs, specialty society chapters, and the accredited CME community. That last one matters here. Continuing education professionals already run needs assessments, design competency-based curricula, document outcomes, and hold accreditation infrastructure. Re-entry is a continuing professional development problem wearing a regulatory costume.

Specialty societies hold something else the regulators lack: the roster. The supervisors and proctors these physicians cannot find are already members.